|
1
|
Sandler RS, Everhart JE, Donowitz M, Adams
E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A and Rubin R: The
burden of selected digestive diseases in the United States.
Gastroenterology. 122:1500–1511. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Everhart JE and Ruhl CE: Burden of
digestive diseases in the United States Part III: Liver, biliary
tract, and pancreas. Gastroenterology. 136:1134–1144. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaechele V, Wabitsch M, Thiere D, Kessler
AL, Haenle MM, Mayer H and Kratzer W: Prevalence of gallbladder
stone disease in obese children and adolescents: Influence of the
degree of obesity, sex, and pubertal development. J Pediatr
Gastroenterol Nutr. 42:66–70. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shaffer EA: Gallstone disease:
Epidemiology of gallbladder stone disease. Best Pract Res Clin
Gastroenterol. 20:981–996. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Portincasa P, Moschetta A and Palasciano
G: Cholesterol gallstone disease. Lancet. 368:230–239. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hofmann AF, Amelsberg A and VanSonnenberg
E: Pathogenesis and treatment of gallstones. N Engl J Med.
328:1854–1855. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lamont JT and Carey MC: Cholesterol
gallstone formation. 2. Pathobiology and pathomechanics. Prog Liver
Dis. 10:165–191. 1992.PubMed/NCBI
|
|
8
|
Turley SD, Daggy BP and Dietschy JM:
Effect of feeding psyllium and cholestyramine in combination on low
density lipoprotein metabolism and fecal bile acid excretion in
hamsters with dietary-induced hypercholesterolemia. J Cardiovasc
Pharmacol. 27:71–79. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Altmann SW, Davis HJ Jr, Zhu LJ, Yao X,
Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, et al:
Niemann-Pick C1 like 1 protein is critical for intestinal
cholesterol absorption. Science. 303:1201–1204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Graf GA, Yu L, Li WP, Gerard R, Tuma PL,
Cohen JC and Hobbs HH: ABCG5 and ABCG8 are obligate heterodimers
for protein trafficking and biliary cholesterol excretion. J Biol
Chem. 278:48275–48282. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu L, Li-Hawkins J, Hammer RE, Berge KE,
Horton JD, Cohen JC and Hobbs HH: Overexpression of ABCG5 and ABCG8
promotes biliary cholesterol secretion and reduces fractional
absorption of dietary cholesterol. J Clin Invest. 110:671–680.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grenier E, Garofalo C, Delvin E and Levy
E: Modulatory role of PYY in transport and metabolism of
cholesterol in intestinal epithelial cells. PLoS One. 7:e409922012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anderson RA, Joyce C, Davis M, Reagan JW,
Clark M, Shelness GS and Rudel LL: Identification of a form of
acyl-CoA: Cholesterol acyltransferase specific to liver and
intestine in nonhuman primates. J Biol Chem. 273:26747–26754. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang W, Jia L, Ma Y, Xie P, Haywood J,
Dawson PA, Li J and Yu L: Ezetimibe restores biliary cholesterol
excretion in mice expressing Niemann-Pick C1-like 1 only in liver.
Biochim Biophys Acta. 1811:549–555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang KX and Denhardt DT: Osteopontin: Role
in immune regulation and stress responses. Cytokine Growth Factor
Rev. 19:333–345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takemoto M, Tada K, Nakatsuka K, Moriyama
Y, Kazui H, Yokote K, Matsumoto T, Saito Y and Mori S: Effects of
aging and hyperlipidemia on plasma osteopontin level. Nihon Ronen
Igakkai Zasshi. 36:799–802. 1999.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang L, Chen JH, Cai D, Wang LY and Zha
XL: Osteopontin and integrin are involved in cholesterol gallstone
formation. Med Sci Monit. 18:BR16–BR23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang L, Chen JH, Cai D, Wang LY and Zha
XL: Osteopontin plays an anti-nucleation role in cholesterol
gallstone formation. Hepatol Res. 41:437–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin J, Shao WQ, Chen ZY, Zhu WW, Lu L, Cai
D, Qin LX, Jia HL, Lu M and Chen JH: Osteopontin deficiency alters
biliary homeostasis and protects against gallstone formation. Sci
Rep. 6:302152016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dietschy JM and Siperstein MD: Effect of
cholesterol feeding and fasting on sterol synthesis in seventeen
tissues of the rat. J Lipid Res. 8:97–104. 1967.PubMed/NCBI
|
|
21
|
Spady DK and Dietschy JM: Sterol synthesis
in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit,
hamster, and rat. J Lipid Res. 24:303–315. 1983.PubMed/NCBI
|
|
22
|
Nervi F, Marinović I, Rigotti A and Ulloa
N: Regulation of biliary cholesterol secretion. Functional
relationship between the canalicular and sinusoidal cholesterol
secretory pathways in the rat. J Clin Invest. 82:1818–1825. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carey MC: Critical tables for calculating
the cholesterol saturation of native bile. J Lipid Res. 19:945–955.
1978.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Davis HJ Jr, Zhu LJ, Hoos LM, Tetzloff G,
Maguire M, Liu J, Yao X, Iyer SP, Lam MH, Lund EG, et al:
Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and
cholesterol transporter and a key modulator of whole-body
cholesterol homeostasis. J Biol Chem. 279:33586–33592. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Buhman KK, Accad M, Novak S, Choi RS, Wong
JS, Hamilton RL, Turley S and Farese RV Jr: Resistance to
diet-induced hypercholesterolemia and gallstone formation in
ACAT2-deficient mice. Nat Med. 6:1341–1347. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang HH and Wang DQ: Reduced
susceptibility to cholesterol gallstone formation in mice that do
not produce apolipoprotein B48 in the intestine. Hepatology.
42:894–904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amigo L, Quinones V, Mardones P, Zanlungo
S, Miquel JF, Nervi F and Rigotti A: Impaired biliary cholesterol
secretion and decreased gallstone formation in apolipoprotein
E-deficient mice fed a high-cholesterol diet. Gastroenterology.
118:772–779. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang DQ, Zhang L and Wang HH: High
cholesterol absorption efficiency and rapid biliary secretion of
chylomicron remnant cholesterol enhance cholelithogenesis in
gallstone-susceptible mice. Biochim Biophys Acta. 1733:90–99. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang ZY, Jiang CY, Wang L, Wang JC, Zhang
SD, Einarsson C, Eriksson M, Han TQ, Parini P and Eggertsen G:
Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from
Chinese gallstone patients. Biochem Biophys Res Commun. 379:49–54.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Li M, Wu S and Tian Y: Combination
of curcumin and piperine prevents formation of gallstones in C57BL6
mice fed on lithogenic diet: Whether NPC1L1/SREBP2 participates in
this process? Lipids Health Dis. 14:1002015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Betters JL and Yu L: NPC1L1 and
cholesterol transport. Febs Lett. 584:2740–2747. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Valasek MA, Repa JJ, Quan G, Dietschy JM
and Turley SD: Inhibiting intestinal NPC1L1 activity prevents
diet-induced increase in biliary cholesterol in Golden Syrian
hamsters. Am J Physiol Gastrointest Liver Physiol. 295:G813–G822.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang HH, Portincasa P, Mendez-Sanchez N,
Uribe M and Wang DQ: Effect of ezetimibe on the prevention and
dissolution of cholesterol gallstones. Gastroenterology.
134:2101–2110. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zúñiga S, Molina H, Azocar L, Amigo L,
Nervi F, Pimentel F, Jarufe N, Arrese M, Lammert F and Miquel JF:
Ezetimibe prevents cholesterol gallstone formation in mice. Liver
Int. 28:935–947. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Duval C, Touche V, Tailleux A, Fruchart
JC, Fievet C, Clavey V, Staels B and Lestavel S: Niemann-Pick C1
like 1 gene expression is down-regulated by LXR activators in the
intestine. Biochem Biophys Res Commun. 340:1259–1263. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
van der Veen JN, Kruit JK, Havinga R,
Baller JF, Chimini G, Lestavel S, Staels B, Groot PH, Groen AK and
Kuipers F: Reduced cholesterol absorption upon PPARdelta activation
coincides with decreased intestinal expression of NPC1L1. J Lipid
Res. 46:526–534. 2005. View Article : Google Scholar : PubMed/NCBI
|
